Chemed Corp. Stock
€535.00
Your prediction
Chemed Corp. Stock
Pros and Cons of Chemed Corp. in the next few years
Pros
Cons
Performance of Chemed Corp. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Chemed Corp. | -0.930% | - | - | - | - | - | - |
Amn Healthcare Svs | -4.720% | -10.619% | -3.810% | -42.938% | -24.627% | -30.822% | 10.612% |
Ensign Group Inc. | 0.910% | 0.000% | -1.786% | - | 6.796% | - | - |
Select Medical Holdings | 1.280% | -0.641% | - | - | - | - | - |
Comments
News
Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend
Stockholders of Chemed Corporation (NYSE:CHE) today elected a slate of 10 directors at the Company’s 2024 annual stockholders’ meeting.
Stockholders ratified the continuation of
Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2024
Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Bank of America Securities Health Care Conference 2024 on Tuesday, May 14, 2024, at 1:40 PM (PDT) at the
Chemed Reports First-Quarter 2024 Results
Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest